Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Uterine Cervical Neoplasms 4Neoplasms 3Breast Neoplasms 3Papillomavirus Infections 2Lung Neoplasms 2Uterine Cervical Diseases 1Squamous Intraepithelial Lesions 1Squamous Cell Carcinoma of Head and Neck 1Smoking 1Pulmonary Atelectasis 1Postural Orthostatic Tachycardia Syndrome 1Postoperative Complications 1Pneumonia 1Pancreatic carcinoma, familial 1Pancreatic cancer, adult 1Multiple Myeloma 1Mastocytosis 1Lung Cancer Screening 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Lymphocytic, Chronic, B-Cell 1HIV Infections 1Financial Stress 1Esophageal Neoplasms 1Colorectal Neoplasms 1Cervical Cancer Screening 1Bronchopulmonary Disease 1Barrett Esophagus 1Adenocarcinoma Of Esophagus 1

Interventions

ceftolozane, tazobactam drug combination 1Ultrasonography 1Observation 1Methylprednisolone 1Mass Screening 1CIMAvax EGF 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pneumonia × Mass Screening × 1 year × Clear all
NCT04663958 2026-04-30

Predictive Value of Ariscat Index In The Development of Pulmonary Complication After Major Abdominal Cancer Surgery

Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital

Completed
410 enrolled

Pulmonary Atelectasis, Neoplasms, Pneumonia, Postoperative Complications

Data powered by HemOnc (CC BY 4.0) Colophon âš¡